Cargando…
Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver
BACKGROUND & AIMS: Fatty liver or nonalcoholic fatty liver disease (NAFLD) is the most common liver disease associated with comorbidities such as insulin resistance and cardiovascular and metabolic diseases. Chronic activation of hypoxic signaling, in particular, hypoxia-inducible factor (HIF)2α...
Autores principales: | Mooli, Raja Gopal Reddy, Rodriguez, Jessica, Takahashi, Shogo, Solanki, Sumeet, Gonzalez, Frank J., Ramakrishnan, Sadeesh K., Shah, Yatrik M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258975/ https://www.ncbi.nlm.nih.gov/pubmed/33798787 http://dx.doi.org/10.1016/j.jcmgh.2021.03.011 |
Ejemplares similares
-
Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022) -
A central role for hypoxia-inducible factor (HIF)-2α in hepatic glucose homeostasis
por: Ramakrishnan, Sadeesh K., et al.
Publicado: (2017) -
Rebuttal to: Inflammation: The Straw That Broke the NAFLD Liver!
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022) -
Liver Steatosis is a Driving Factor of Inflammation
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022) -
Intestinal HIF-2α Regulates GLP-1 Secretion via Lipid Sensing in L-Cells
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2021)